ISSN: 2332-0877

Jornal de doenças infecciosas e terapia

Acesso livre

Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.

Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores

Abstrato

Herpes Simplex Encephalitis in Childhood

Bhagirathi Dwibedi and Sushil Kumar Rathore

Acute Encephalitis Syndrome (AES) is one of the important health problems in childhood that leads to severe morbidity, mortality and sequelae. Herpes Simplex Virus (HSV) attributing towards such viral encephalitis carries importance with respect to its global prevalence challenging pathogenesis and morbidity outcomes. This report provides a review on several studies on epidemiology, pathogenesis (molecular and immune mechanism), clinical presentation, diagnosis and treatment related to Herpes simplex encephalitis (HSE) in children. It highlights wide spread distribution of HSE in children throughout the globe with mortality upto 70% in spite of availability of effective antiviral agent. In this context early diagnosis is a challenge as early CSF studies and imaging may not provide confirmatory diagnosis so an empirical treatment of Acyclovir will be of value. The review pointed that LATs play an important role in molecular modulation but it is still challenging to explain the exact cellular mechanism. The current antivirals available have shown to be potentially useful in curing symptomatic illness but eliminating neuronal carrier stage is still an issue of research for drug development. Better understanding of biochemical and immune response if available can open the scope for use of immunomodulators that can prevent reactivation. This review also focuses upon challenges in immunopathogenesis and treatment and vaccine development.